Education
About Us
Working with TipRanks
Follow Us
Delta-Fly Pharma, Inc. (JP:4598)
:4598
RESEARCH TOOLSreports
4598 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥403.00 - ¥793.00
Previous CloseN/A
Volume237.90K
Average Volume (3M)282.16K
Market Cap
¥6.22B
Enterprise Value¥6.57B
Total Cash (Recent Filing)¥338.83M
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Nov 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-35.43
Shares Outstanding11,525,000
10 Day Avg. Volume225,460
30 Day Avg. Volume282,156
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4598 FAQ
What was Delta-Fly Pharma, Inc.’s price range in the past 12 months?
Delta-Fly Pharma, Inc. lowest stock price was ¥403.00 and its highest was ¥793.00 in the past 12 months.
What is Delta-Fly Pharma, Inc.’s market cap?
Delta-Fly Pharma, Inc.’s market cap is ¥6.22B.
When is Delta-Fly Pharma, Inc.’s upcoming earnings report date?
Delta-Fly Pharma, Inc.’s upcoming earnings report date is Nov 13, 2025 which is in 52 days.
How were Delta-Fly Pharma, Inc.’s earnings last quarter?
Delta-Fly Pharma, Inc. released its earnings results on Aug 08, 2025. The company reported -¥35.43 earnings per share for the quarter, missing the consensus estimate of N/A by -¥35.43.
Is Delta-Fly Pharma, Inc. overvalued?
According to Wall Street analysts Delta-Fly Pharma, Inc.’s price is currently Overvalued.
Does Delta-Fly Pharma, Inc. pay dividends?
Delta-Fly Pharma, Inc. does not currently pay dividends.
What is Delta-Fly Pharma, Inc.’s EPS estimate?
Delta-Fly Pharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Delta-Fly Pharma, Inc. have?
Delta-Fly Pharma, Inc. has 11,525,000 shares outstanding.
What happened to Delta-Fly Pharma, Inc.’s price movement after its last earnings report?
Delta-Fly Pharma, Inc. reported an EPS of -¥35.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.566%.
Which hedge fund is a major shareholder of Delta-Fly Pharma, Inc.?
Currently, no hedge funds are holding shares in JP:4598
Company Description
Delta-Fly Pharma, Inc.
Delta-Fly Pharma, Inc. (4598) is a pharmaceutical company headquartered in Japan. The company focuses on the research and development of innovative cancer treatments, leveraging its expertise in drug discovery and clinical development. Delta-Fly Pharma aims to address unmet medical needs in oncology through its pipeline of novel therapeutic candidates. The company's core products and services revolve around its proprietary compounds that are designed to improve the efficacy and safety of existing cancer therapies.
Technical Analysis
OncoTherapy Science
―
Chiome Bioscience Inc.
―
Oncolys BioPharma, Inc.
―
BrightPath Biotherapeutics Co.Ltd.
―
Kringle Pharma, Inc.
―